Farms.com Home   News

SCA Invests In WLPIP Premium Increase Compensation

The Saskatchewan Cattlemen’s Association is contributing up to $1 million to partner with the Province to offset the increase in producer premiums associated with COVID-19 for the Western Livestock Price Insurance Program.
 
Last month, Minister Marit announced that the Province would help offset the increase in premiums with $5 million of provincial funds. 
 
Work continued to try to bring the federal government onside to cover the rest of the premium increase, but that has not happened.
 
SCA's contribution of up to $1 million along with the provinces $5 million will help offset an additional eight per cent of the COVID-19 impact on WLPIP premiums.
 
Cow-calf producers are entering the final week to purchase calf price insurance through WLPIP with the final deadline of June 18th.
 
Premium tables are published on Tuesday, Wednesday, and Thursday. 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.